Unlike compounded medications, these branded options from major pharmaceutical companies are tested rigorously, guaranteeing their consistency and potency
7 Subcutaneous semaglutide was approved in 2021 and 2022 as Wegovy for weight loss in patients 12 and older after the STEP1 trial showed patients who took subcutaneous semaglutide had a -14.9% body weight reduction (-15.3kg) compared to -2.4% (-2.6kg) with placebo after 68 weeks
Research Vial Dosing Phase III Equivalent Phase Day 1 onward Timing Every day Daily Dose 2 mg Notes No titration
Skin Lightening for Intimate Areas Many patients are bothered by skin darkening in intimate areas of the skin, such as the underarms, vaginal, groin, nipples and genital area
It all starts with a consultation with your doctor, to make sure this peptide is the right fit for you
Calcium Calcium strengthens bones and teeth, supports muscle contractions, and aids in nerve transmission